Market Research Trending

  Particle therapy is an emerging area of external beam radiotherapy in which external beams of neutrons or other energetic particles are used to kill cancerous cells in the patient's body. Multi ion particle therapy systems are capable of generating both proton and heavy ion in one accelerator, which helps the system offer flexible treatment according to various symptom of patients and tumor sites. The most common cancer that can be treated by this method are leukemia, cervical cancer, prostate cancer, melanoma, and Hodgkin's lymphoma. High prevalence of cancer is expected to propel growth of the particle therapy market . According to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. In May 2019, Hitachi, Ltd. signed a contract with Himed Hospital Management (Xuzhou) Co., Ltd., China, to deliver particle therapy system with capability of irradiating both proton and heavy ion. One of ...

  Particle therapy is an emerging area of external beam radiotherapy in which external beams of neutrons or other energetic particles are used to kill cancerous cells in the patient's body. Multi ion particle therapy systems are capable of generating both proton and heavy ion in one accelerator, which helps the system offer flexible treatment according to various symptom of patients and tumor sites. The most common cancer that can be treated by this method are leukemia, cervical cancer, prostate cancer, melanoma, and Hodgkin's lymphoma. High prevalence of cancer is expected to propel growth of the particle therapy market . According to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. In May 2019, Hitachi, Ltd. signed a contract with Himed Hospital Management (Xuzhou) Co., Ltd., China, to deliver particle therapy system with capability of irradiating both proton and heavy ion. One of ...